TLR4与β2GPI/抗β2GPI复合物在动脉粥样硬化中的作用研究
摘要
动脉粥样硬化(Atherosclerosis,AS)所引起的血栓形成及心血管疾病是目前全世界导致人类死亡的主要原因,对人类的生存和生活质量是一种巨大的威胁和破坏。弗雷明汉研究提出了一系列动脉粥样硬化的危险因素,例如高胆固醇血症、高血压、吸烟、肥胖和家族史等,但这些危险因素已不足以解释该病的发生发展,有关AS的自身免疫因素越来越受到关注。
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2016年第2期262-266,共5页
Chinese Journal of Immunology
基金
国家自然科学基金资助项目(No.81370614)
参考文献30
-
1Zhou H, Yan Y, Xu G, et al. Toll-like receptor (TLR)-4 mediates anti-132GPI/132GPI-induced tissue factor expression in THP-1 cells [ J]. Clin Exp Immunol,2011,163 (2) : 189-198.
-
2周红,谷俊侠,许文荣.APS IgG通过非Fc受体途径诱导血液单核细胞表达TF活性[J].中国免疫学杂志,2003,19(8):561-564. 被引量:13
-
3Conti F, Spinelli FR, Alessandri C, et al. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on ~2GPI-specific T cell response [ J]. Arterioscler Thromb ~asc Biol,2014,34(3) :661-668.
-
4Varela C, De Haro J, Bleda S, et al. Circulating anti-beta2- glycoprotein I antibodies are associated with endothelial dysfunction, inflammation, and high nitrite plasma levels in patients with intermittent claudication [ J ]. Int J Imqam, 2013, 2013 : 168079.
-
5Matsuura E, Lopez LR, Shoenfeld Y, et al. 132-glycoprotein I andoxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity? [ J]. Autoimmun Rev ,2012,12 (2) : 241-249.
-
6Nowak B, Szmyrka-Kaczmarek M, Durazihska A, et al. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus [ J]. Adv Clin Exp Med, 2012,21 (3) :331-335.
-
7Bergnr JS, Roekman CB, Guyer KE, et al. Proatherogenic oxidized low-density lipoprotein/[$2-glycoprotein I eomplexes in arterial and venous disease [ J ]. J Immunol Res,2014 ;2014 : 234316.
-
8Nagarajan S. Anti-OxLDL IgG blocks OxLDL interaction with CD36,but promotes FegammaR, CD32A-dependent inflammatory cell adhesion[ J]. Immunol Lett ,2007,108 ( 1 ) :52-61.
-
9Xu Y, Kong X, Zhou H, et al. oxLDIM[32GPI/anti-[32GPI complex induced maerophage differentiation to foam cell involving TLR4/ NF-kappa B signal transduction pathway [ J ]. Thromb Res, 2014, 134(2) :384-392.
-
10Miller YI, Choi SH, Wiesner P, et al. The SYK side of TLR4 : signalling mechanisms in response to LPS and minimally oxidized LDL[ J]. Br J Pharmaco1,2012,167 (5) :990-999.
二级参考文献41
-
1Roubey R A S, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis[J]. Lancet, 1997;350:1491-1493.
-
2Roubey R A S. Update on antiphospholipid antibodies[ J]. Current Opinion in Rheumatology,2000; 12:374-378.
-
3Amengual O,Atsumi T, Khamashta M A et al .The role tithe tissue factor pathway in the hypercoagulable state in patients with the antipholipid syndrome[J] .Thromb Haemost, 1998;79:276-281.
-
4Dobado-Berrios PM, Lopez-Pedrera C, Velasco F et al. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome [ J ]. Thromb Haemost, 1999; 82:1578-1582.
-
5Conkling P R, Greenberg C S,Weinherg J B. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line 13937 and peripheral blood monocytes[J]. Blood, 1998;72:128-133.
-
6Cusdrado M J, Lopez-Pedrera C, Khamashta M A et al . Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression[J] .Arthritis Rheum, 1997;40:834-841.
-
7Key N S,Slungaant A, Dandelet L et al.Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease [ J ].Blood, 1998;91:4216-4223.
-
8Reverter J C,Tassies D,Font J et al .Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes[J] .Arthritis Rheum, 1998;41 : 1420-1427.
-
9Salemink I, Blezer R, Willems G M et al. Antibodies to β2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor[J]. Thromb Haemost, 2000; 84: 653-656.
-
10Martinuzzo M E, Forastiero R R,Carreras L O.Anti-β2 glycoprotein I antibodies:detection and asacciation with thrombosis[J]. Br J Haematol,1995;89:397-402.
共引文献13
-
1周红.抗磷脂抗体与血栓形成[J].江苏大学学报(医学版),2004,14(5):445-448. 被引量:6
-
2周红,王婷,孙晓春,陈巧林,许文荣,胡嘉波.地拉卓干预APSIgG诱导血液单核细胞组织因子活性的实验研究[J].中国药学杂志,2004,39(10):755-758.
-
3HongZHOU.Dilazep and dipyridamole inhibit tissue factor expressionon monocytes induced by IgG from patientswith antiphospholipid syndrome[J].Acta Pharmacologica Sinica,2004,25(10):1366-1371. 被引量:2
-
4王婷,周红,俞颖,胡红心.抗β_2糖蛋白Ⅰ抗体诱导血液单核细胞表达组织因子活性的机制探讨[J].江苏大学学报(医学版),2006,16(1):1-4. 被引量:3
-
5李萍,朱付凡.抗磷脂抗体对妊娠的影响[J].中国优生与遗传杂志,2007,15(3):115-117. 被引量:6
-
6严一红,周红,周保成,文海平,许国莹,周芳.TLR4在anti-β2GPⅠ/β2GPⅠ复合物诱导THP-1细胞表达TF中的作用探讨[J].中国免疫学杂志,2010,26(5):396-401. 被引量:10
-
7俞颖,谭潘丽,钱丽丽.膜联蛋白A_2介导β_2糖蛋白Ⅰ/抗β_2糖蛋白Ⅰ复合物刺激单核细胞上调表达组织因子[J].中国药物与临床,2010,10(12):1337-1340. 被引量:2
-
8陈东东,周红,解鸿翔,张先梅,夏龙飞,王婷,王海波.MAPKs在anti-β_2 GPI/β_2 GPI刺激THP-1细胞表达TF过程中的作用探讨[J].中国免疫学杂志,2012,28(2):99-103. 被引量:2
-
9王海波,周红,解鸿翔,王婷,穆原,陈东东,夏龙飞.抗β_2GPI/β_2GPI复合物激活THP-1细胞表达炎性相关因子[J].临床检验杂志,2012,30(5):347-350. 被引量:5
-
10刘小云,洪梅.组织因子在系统性红斑狼疮动脉粥样硬化病变中的作用及机制[J].临床血液学杂志,2012,25(5):616-618.
-
1梁传乐.浅论儿童特发性血小板减少性紫癜的发病原因和治疗方法[J].当代医药论丛,2014,12(12):8-9.
-
2糖尿病不可怕可怕的是并发症②[J].健康指南(中老年),2015,0(4):10-12.
-
3张梅香.血栓通联合前列腺素E_1治疗糖尿病神经病变[J].现代中西医结合杂志,2011,20(1):63-63. 被引量:3
-
4刘新玉.维生素D缺乏可能成为心血管疾病高发的又一诱因[J].中国医药生物技术,2008,3(1):10-10.
-
5李晓玲,刘莉莉.心血管疾病危险因素的研究现状[J].现代临床医学,2007,33(4):314-315. 被引量:16
-
6汤雯,贾继东.儿童自身免疫性肝病研究进展[J].传染病信息,2006,19(3):109-111. 被引量:2
-
7张佳李红.甲状腺功能亢进症合并肺动脉高压临床分析[J].中华内分泌代谢杂志,2014,30(2):133-134. 被引量:9
-
8李剑虹.弗雷明汉心脏研究:血脂异常流行趋势调查[J].中华预防医学杂志,2012,46(5):413-413.
-
9曾婷,蒋晓真.自身免疫与糖尿病大血管病变[J].国际内分泌代谢杂志,2012,32(5):348-350.
-
10牛瑞兰,刘静.糖尿病听力损害研究新进展[J].医学综述,2012,18(23):4003-4005. 被引量:5